Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals

BSE403.8014.95 (+3.84 %)

PREV CLOSE ( ) 388.85

OPEN PRICE ( ) 388.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 10353

TODAY'S LOW / HIGH ( )388.00 410.65

52 WK LOW / HIGH ( )324.5 640.05

NSE407.1518.5 (+4.76 %)

PREV CLOSE( ) 388.65

OPEN PRICE ( ) 388.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 407.15 (188)

VOLUME 287553

TODAY'S LOW / HIGH( ) 388.00 411.40

52 WK LOW / HIGH ( )321.95 640.85

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-03 1988

Management Info

- Chairman Shivakumar Pattabhiraman - Managing Director

Registered Office

Address Sarita Vihar,Delhi - Mathura Road,,
New Delhi,
Delhi-110076

Phone 011- 26925858 / 26925801

Email imcl@apollohospitals.com

Website https://www.apollohospitals.com/

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

19Jan Indraprastha Medical Corporation infor
Indraprastha Medical Corporation has informed that a meeting of the Boar..

19Dec Indraprastha Medical Corporation infor
Indraprastha Medical Corporation has informed that the trading window of..

17Oct Indraprastha Medical Corporation infor
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

01Sep Indraprastha Medical Corporation infor
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (L..

17Jun Indraprastha Medical Corporation infor
Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Di..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	410	1609.9
Gross Profit	563.9	2163.2
Operating Profit	691	2669.2
Net Sales	3716.1	13563.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE) 5310.00 (2.05%)	M.Cap ( in Cr)5810.34
Dr Agarwals Eye Hsp (BSE) 4800.00 (2.06%)	M.Cap ( in Cr)2319.76
Nephrocare Health Se (BSE) 553.35 (7.58%)	M.Cap ( in Cr)5552.35
Narayana Hrudayalay (BSE) 1688.40 (2.00%)	M.Cap ( in Cr)34504.28
Fortis Healthcare (BSE) 843.50 (2.85%)	M.Cap ( in Cr)63680.72

Shareholding Pattern

	PROMOTERS	51%
	NON-INSTITUTION	45.44%
	FI/BANKS/INSURANCE	0%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Small Cap Fund(G)	0.39
Motilal Oswal BSE H...	0.16
Bandhan BSE Healthc...	0.16

Risk Disclosures on Derivatives

Smart Quotes

INDRAPRASTHA MEDICAL CORPORATION LTD.